Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.

from NDTV Profit-Latest https://ift.tt/4PrSugy
via xxx

Comments

Popular posts from this blog

Inside Pic From Karan Johar's Birthday Party With Varun Dhawan-Natasha Dalal, Neha Dhupia-Angad Bedi And Kunal Kemmu-Soha Ali Khan

Mahesh Babu Remembers Father Krishna On His Birth Anniversary: "You Are Deeply Missed"

Savi Review: Anil Kapoor Manages To Be One Of The Bright Spots Of Harshvardhan Rane, Divya Khossla's Film